Kim Bouillon

Social inequalities in multimorbidity, frailty, disability, and transitions to mortality: a 24-year follow-up of the Whitehall II cohort study

Aline Dugravot, Aurore Fayossé, Julien Dumurgier et al. · The Lancet Public Health · 2019 · 341 citations · Full text

Medicine, Health Sciences, Frailty +16

Long-Term Cardiovascular Mortality After Radiotherapy for Breast Cancer

Kim Bouillon, Nadia Haddy, Suzette Delaloge et al. · Journal of the American College of Cardiology · 2011 · 232 citations

Medicine, Oncology, Radiation Oncology +14

Comparison of the Short-Term Risk of Bleeding and Arterial Thromboembolic Events in Nonvalvular Atrial Fibrillation Patients Newly Treated With Dabigatran or Rivaroxaban Versus Vitamin K Antagonists

Géric Maura, Pierre‐Olivier Blotière, Kim Bouillon et al. · Circulation · 2015 · 167 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

Risk of bleeding and arterial thromboembolism in patients with non-valvular atrial fibrillation either maintained on a vitamin K antagonist or switched to a non-vitamin K-antagonist oral anticoagulant: a retrospective, matched-cohort study

Kim Bouillon, Marion Bertrand, Géric Maura et al. · The Lancet Haematology · 2015 · 95 citations

Medicine, Cardiology, Pharmacotherapy +17

Diabetes Risk Factors, Diabetes Risk Algorithms, and the Prediction of Future Frailty: The Whitehall II Prospective Cohort Study

Kim Bouillon, Mika Kivimäki, Mark Hamer et al. · Journal of the American Medical Directors Association · 2013 · 82 citations · Full text

Medicine, Geriatric Medicine, Frailty +14